InvestSMART

Raptor Metals Ltd (ASX: RAP) - Announcements

- Current share price for RAP : $0.020

ASX company news and announcements for Raptor Metals Ltd (RAP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Raptor Metals Ltd (RAP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Raptor Metals Ltd (RAP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Raptor Metals Ltd (RAP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$8 Annual Report 2016 28 Sep 2016 7:00PM $0.505 $0.020 fallen by 96.04%
$8 Appendix 3B & Section 708A Notice 16 Sep 2016 5:23PM $0.425 $0.020 fallen by 95.29%
$8 ResApp Begins Evaluation with Humanitarian Organisation 15 Sep 2016 8:29AM $0.390 $0.020 fallen by 94.87%
$8 Change in substantial holding 9 Sep 2016 8:27AM $0.370 $0.020 fallen by 94.59%
$8 Appendix 4E - Preliminary Final Report 31 Aug 2016 7:33PM $0.360 $0.020 fallen by 94.44%
$8 ResApp Wins Global Grand Finals at Talent Unleashed Awards 19 Aug 2016 9:14AM $0.335 $0.020 fallen by 94.03%
$8 ResApp Expands into Management of Respiratory Disease 18 Aug 2016 9:00AM $0.320 $0.020 fallen by 93.75%
$8 Change of Auditor 4 Aug 2016 6:51PM $0.355 $0.020 fallen by 94.37%
$8 Appendix 4C - quarterly 29 Jul 2016 6:16PM $0.385 $0.020 fallen by 94.81%
$8 Bioshares Biotech Summit Presentation 29 Jul 2016 9:14AM $0.400 $0.020 fallen by 95%
$8 Section 708A Notice 22 Jul 2016 5:45PM $0.350 $0.020 fallen by 94.29%
$8 Appendix 3B 22 Jul 2016 5:34PM $0.350 $0.020 fallen by 94.29%
$8 ResApp Wins Category at the 2016 Talent Unleashed Awards 22 Jul 2016 8:45AM $0.330 $0.020 fallen by 93.94%
$8 Massachusetts General Hospital for US Clinical Study Site 20 Jul 2016 9:23AM $0.320 $0.020 fallen by 93.75%
$8 Becoming a substantial holder 20 Jul 2016 8:26AM $0.320 $0.020 fallen by 93.75%
$8 Appendix 3B 15 Jul 2016 4:23PM $0.290 $0.020 fallen by 93.10%
$8 Ceasing to be a substantial holder 7 Jul 2016 2:37PM $0.295 $0.020 fallen by 93.22%
$8 Ceasing to be a substantial holder 7 Jul 2016 2:33PM $0.295 $0.020 fallen by 93.22%
$8 Appendix 3B 7 Jul 2016 1:52PM $0.285 $0.020 fallen by 92.98%
$8 Response to ASX Price and Volume Query 7 Jul 2016 1:30PM $0.285 $0.020 fallen by 92.98%
$8 Update on US Clinical Study 30 Jun 2016 8:50AM $0.390 $0.020 fallen by 94.87%
$8 Appendix 3B 28 Jun 2016 5:59PM $0.400 $0.020 fallen by 95%
$8 Positive Preliminary Results from Adult Clinical Study 21 Jun 2016 9:06AM $0.370 $0.020 fallen by 94.59%
$8 Trading Halt 20 Jun 2016 9:20AM $0.370 $0.020 fallen by 94.59%
$8 Release of Restricted Securities 10 Jun 2016 5:10PM $0.450 $0.020 fallen by 95.56%

476 - 500 of 581 results

Page 20 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.